Cue Share Price
NASDAQ: CUE | Small Cap | HealthcareCue Stock Performance
Cue Share Price Today
As of 19 November 2026, Cue Biopharma, Inc.'s share price is $4.28. The stock opened at $3.43, compared to its previous close of $3.23. During today's trading session, Cue Biopharma, Inc.'s share price traded between $3.29 and $4.44, with an average price of $3.87. Over the past 52 weeks, the stock has recorded a high of $45.21 and a low of $0.17. In terms of performance, Cue Biopharma, Inc.'s share price has declined by 80.98% over the last six months and is up 549.47% on a year-on-year basis.
Cue Share Price Chart
Cue Quarterly Profit & Loss
All figures in USD
Cue Annual Profit & Loss
All figures in USD
Cue Balance Sheet
All figures in USD Million
Cue Cash Flow
All figures in USD Million
Corporate Actions
About Cue
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
Cue Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $21.20 | $4.33 | -78.95% |
Oct 2026 | $25.54 | $20.55 | -20.66% |
Sep 2026 | $25.51 | $25.90 | -7.47% |
Aug 2026 | $27.10 | $27.99 | +2.90% |
Jul 2026 | $30.45 | $27.20 | -12.17% |
Jun 2026 | $23.15 | $30.97 | +37.64% |
May 2026 | $33.25 | $22.50 | +53.06% |
Apr 2026 | $0.22 | $14.70 | +6,521.62% |
Mar 2026 | $0.28 | $0.22 | -23.18% |
Feb 2026 | $0.33 | $0.29 | -14.24% |
Jan 2026 | $0.32 | $0.34 | +10.86% |
Dec 2025 | $0.61 | $0.30 | -53.87% |